Longeveron Competitors
| LGVN Stock | USD 0.54 0.02 3.57% |
Longeveron LLC vs Processa Pharmaceuticals Correlation
Very poor diversification
The correlation between Longeveron LLC and PCSA is 0.83 (i.e., Very poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Longeveron LLC and PCSA in the same portfolio, assuming nothing else is changed.
Moving together with Longeveron Stock
| 0.7 | EDIT | Editas Medicine Earnings Call This Week | PairCorr |
Moving against Longeveron Stock
| 0.71 | DSGN | Design Therapeutics | PairCorr |
| 0.71 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.59 | KYTX | Kyverna Therapeutics | PairCorr |
| 0.51 | ENGN | enGene Holdings Common | PairCorr |
| 0.4 | 63E | ONWARD MEDICAL BV | PairCorr |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Longeveron LLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Longeveron LLC Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Longeveron LLC and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Longeveron and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Longeveron LLC does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Longeveron Stock performing well and Longeveron LLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Longeveron LLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LPTX | 14.85 | 6.69 | 0.63 | (7.00) | 6.90 | 25.00 | 65.13 | |||
| DARE | 2.98 | (0.11) | 0.00 | (0.09) | 0.00 | 6.55 | 26.52 | |||
| CTXR | 4.69 | (0.48) | 0.00 | (0.14) | 0.00 | 11.11 | 38.23 | |||
| PULM | 3.27 | (0.80) | 0.00 | 1.27 | 0.00 | 6.62 | 51.95 | |||
| ATHA | 4.12 | 0.62 | 0.10 | (0.52) | 4.10 | 6.70 | 71.83 | |||
| ASBP | 8.57 | (2.50) | 0.00 | 1.82 | 0.00 | 19.52 | 66.08 | |||
| PALI | 5.75 | 0.30 | 0.03 | 10.53 | 6.57 | 13.66 | 31.35 | |||
| CRIS | 4.18 | (0.53) | 0.00 | (0.15) | 0.00 | 10.62 | 33.70 | |||
| FBLG | 5.98 | (0.11) | 0.00 | (0.08) | 0.00 | 14.71 | 47.13 | |||
| PCSA | 8.31 | (0.47) | 0.00 | 3.07 | 0.00 | 11.68 | 164.28 |
Cross Equities Net Income Analysis
Compare Longeveron LLC and related stocks such as Leap Therapeutics, Dare Bioscience, and Citius Pharmaceuticals Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DARE | (19.6 M) | (19.6 M) | (22.1 M) | (17.1 M) | (23.3 M) | (39.6 M) | (39.3 M) | (11.5 M) | (16.7 M) | (14.3 M) | (27.4 M) | (38.7 M) | 406.8 M | (30.2 M) | (4.1 M) | (4.7 M) | (4.4 M) |
| CTXR | (26.3 K) | (22 K) | (31.4 K) | (1.3 M) | (2.9 M) | (8.3 M) | (10.4 M) | (12.5 M) | (15.6 M) | (17.5 M) | (23.1 M) | (33.6 M) | (32.5 M) | (39.1 M) | (37.4 M) | (33.7 M) | (32 M) |
| PULM | (30 K) | (30 K) | (523 K) | (3.1 M) | (24.1 M) | (26.2 M) | (27.8 M) | (18.1 M) | (20.6 M) | (20.6 M) | (19.3 M) | (20.2 M) | (18.7 M) | (14.1 M) | (9.6 M) | (8.6 M) | (9 M) |
| ASBP | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | (25.5 K) | 3.3 M | 4.5 M | (12.5 M) | (11.3 M) | (10.7 M) |
| PALI | (1.7 M) | (12.5 M) | (10.1 M) | (19.8 M) | (22.6 M) | (20.9 M) | (21.1 M) | (15.7 M) | (4.9 M) | (8.4 M) | (10.3 M) | (26.6 M) | (14.3 M) | (12.3 M) | (14.4 M) | (13 M) | (13.6 M) |
| CRIS | (12.1 M) | (9.9 M) | (16.4 M) | (12.3 M) | (18.7 M) | (59 M) | (60.4 M) | (53.3 M) | (32.6 M) | (32.1 M) | (29.9 M) | (45.4 M) | (60.3 M) | (47.4 M) | (43.4 M) | (49.9 M) | (52.4 M) |
| FBLG | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.2 M) | (1.6 M) | (5.1 M) | (16.5 M) | (11.2 M) | (10 M) | (10.5 M) |
| PCSA | (160 K) | (940 K) | (2.4 M) | (3.1 M) | (4.5 M) | (3.4 M) | (3.4 M) | (1.9 M) | (3.8 M) | (3.4 M) | (19 M) | (11.4 M) | (27.4 M) | (11.1 M) | (11.9 M) | (10.7 M) | (11.2 M) |
Longeveron LLC and related stocks such as Leap Therapeutics, Dare Bioscience, and Citius Pharmaceuticals Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Longeveron LLC financial statement analysis. It represents the amount of money remaining after all of Longeveron LLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Longeveron LLC Competitive Analysis
The better you understand Longeveron LLC competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Longeveron LLC's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Longeveron LLC's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Longeveron LLC Competition Performance Charts
Five steps to successful analysis of Longeveron LLC Competition
Longeveron LLC's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Longeveron LLC in relation to its competition. Longeveron LLC's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Longeveron LLC in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Longeveron LLC's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Longeveron LLC, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Longeveron LLC position
In addition to having Longeveron LLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Staples ETFs Thematic Idea Now
Consumer Staples ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Staples ETFs theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Staples ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Longeveron LLC Correlation with its peers. To learn how to invest in Longeveron Stock, please use our How to Invest in Longeveron LLC guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Will Biotechnology sector continue expanding? Could Longeveron diversify its offerings? Factors like these will boost the valuation of Longeveron LLC. Expected growth trajectory for Longeveron significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Longeveron LLC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.98) | Revenue Per Share | Quarterly Revenue Growth (0.82) | Return On Assets | Return On Equity |
Understanding Longeveron LLC requires distinguishing between market price and book value, where the latter reflects Longeveron's accounting equity. The concept of intrinsic value - what Longeveron LLC's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Longeveron LLC's price substantially above or below its fundamental value.
Understanding that Longeveron LLC's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Longeveron LLC represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Longeveron LLC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.